Market Place
Sourcing Support
Enforcement Report - Week of December 13, 2023
13 Dec 2023 //
FDA
Enforcement Report - Week of October 25, 2023
25 Oct 2023 //
FDA
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
YICHANG`s Generic Bupropion Hydrochloride Receives Approval in the U.S.
09 Jan 2023 //
FDA
Enforcement Report - Week of May 18, 2022
19 May 2022 //
FDA
Axsome Therapeutics announces publication of pivotal ascend PII trial of AXS-05
18 May 2022 //
PRESS RELEASE
Granules` Generic Bupropion Hydrochloride Receives Approval in the U.S.
02 Feb 2022 //
FDA
Yichang`s Generic Bupropion Hydrochloride Receives Approval in the U.S.
03 Jan 2022 //
FDA
Currax Appoints Ed Cinca to SVP, Global Marketing & Strategic Alliance
26 Oct 2021 //
PRNEWSWIRE
Health Canada Issues Recall of Sun Pharma`s TARO-Bupropion XL
13 Sep 2021 //
HEALTH CANADA
NIDA-Funded Study Evaluating Extended-Release Injectable Naltrexone Plus
14 Jan 2021 //
PRNEWSWIRE
Cadila Pharmaceuticals` Generic Bupropion HCL Receives Approval in U.S
16 Jan 2020 //
FDA
Dr. Reddy`s Labs launches generic Zyban in US market
05 Sep 2019 //
PHARMABIZ
Dr. Reddy`s Laboratories announces the launch of Bupropion Hydrochloride (SR)
03 Sep 2019 //
BUSINESSWIRE
Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.
22 Aug 2019 //
PATENT DOCS
Naltrexone/bupropion (Mysimba) risk of adverse reactions affect ability to drive
19 Aug 2019 //
GOVUK
How the Pharmaceutical Industry is Looking to Treat Low Sex Drive
10 Jul 2019 //
BIOSPACE
Graviti Pharm`s Generic Bupropion Hydrochloride Receives Approval in US
28 Jan 2019 //
FDA
Nalpropion Pharmaceuticals Expands Agreement with iNova Pharmaceuticals
19 Dec 2018 //
FIRSTWORDPHARMA
Enforcement Report - Week of November 14, 2018
14 Nov 2018 //
FDA
Accord`s Generic Bupropion Hydrochloride Receives Approval in US
03 Nov 2018 //
FDA
Yichang Humanwell`s Generic Bupropion Hydrochloride Receives Approval in US
19 Oct 2018 //
FDA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
11 Sep 2018 //
FORBES
Enforcement Report - Week of August 22, 2018
22 Aug 2018 //
FDA
Eisai obesity drug Belviq may have an edge with new heart safety data
19 Jul 2018 //
FIERCE PHARMA
Alembic Pharma gets US FDA approval for bupropion HCl tablets
11 Jun 2018 //
PHARMABIZ
Alembic Pharm’s Generic Bupropion Hydrochloride Receives Approval In US
11 Jun 2018 //
FDA
Enforcement Report - Week of April 11, 2018
11 Apr 2018 //
FDA
With debt looming, browbeaten diet pill maker Orexigen goes bankrupt
13 Mar 2018 //
ENDPTS
Enforcement Report - Week of January 31, 2018
31 Jan 2018 //
FDA
Final NHS ‘no’ for obesity pill Mysimba
12 Dec 2017 //
PHARMA TIMES
Orexigen Announces Commercialization & Distributorship Agreement with Merck KGaA
13 Nov 2017 //
PR NEWSWIRE
Twi Pharm’s Generic Bupropion Hydrochloride Receives Approval In US
08 Nov 2017 //
FDA
NICE bars obesity pill from routine NHS use
31 Jul 2017 //
PHARMA TIMES
Orexigen Announces Expansion distribution Agreement, Biologix FZCO for Contrave
26 Jul 2017 //
PR NEWSWIRE
Enforcement Report - Week of July 5, 2017
05 Jul 2017 //
FDA
NICE rejects Orexigen’s weight-loss pill
05 May 2017 //
PHARMA TIMES
Enforcement Report - Week of April 19, 2017
19 Apr 2017 //
FDA
Sciegen Pharms Generic Bupropion Hydrochloride Receives Approval In US
13 Apr 2017 //
FDA
Lupin’s Generic Bupropion Hydrochloride Receives Approval In US
12 Apr 2017 //
FDA
Lupin receives FDA approval for generic Wellbutrin XL Tablets
10 Apr 2017 //
INDIAN INFOLINE
Sun Pharma recalls 2.7 lakh bottles of antidepressant in US
07 Feb 2017 //
MONEY CONTROL
Orexigen Announces Spanish Launch of Mysimba
26 Jan 2017 //
PR NEWSWIRE
USFDA Allows Pfizer to Remove Boxed Warning from Chantix Labeling
20 Dec 2016 //
PHARMABIZ
FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix
17 Dec 2016 //
NASDAQ
Orexigen Announces Commercialization & Distributorship Agreement with Consilient
08 Dec 2016 //
PR NEWSWIRE
Sun Pharma, Cadila Healthcare Recall Products from US Market
01 Dec 2016 //
BUSINESS STANDARD
FDA re-inspection of Sun’s troubled Halol plant said to be underway
21 Nov 2016 //
FIERCE PHARMA
Valeant Pharma to commercialise Orexigen Therapeutics` Contrave
10 Nov 2016 //
PHARMABIZ
Valeant`s still raising prices on long-generic Wellbutrin XL. Who`s paying up?
19 Oct 2016 //
FIERCE PHARMA
Sun will recall 31,762 bottles of anti-depressant
12 Oct 2016 //
BUSINESS STANDARD
Cipla gets USFDA nod for generic anti-depressant drug
30 Aug 2016 //
ECONOMIC TIMES
Heritage Pharma Generic Bupropion Hydrochloride Approved in US
19 Aug 2016 //
FDA
Sciegen Pharms Inc ANDA Bupropion Hydrochloride Approved in US
17 Aug 2016 //
FDA
